Table of Contents
<< Previous Issue | Oct 2006 (Vol: 2006, Issue: 76) | Next Issue >> |
- Section: Business Commentaries
-
Controlling Value in Deals
- Section: Cartoons
-
Angel
- Section: Company Profile
-
UCB SA
- Section: Deal Trackers
-
Elaprase (idursulfase)
- Section: Distribution & Marketing
-
Salix Licenses Right to Market and Distribute Sanvar® from Debiopharm
- Section: Features
-
Drastic Measures: Ligand Sells All its Marketed Products
-
A Hostile Genzyme and AnorMED Unrest: Changing Times for the Biotech Industry
-
Paying the Right Price in Biotech Acquisitions
-
Therapy Focus: Wound Care
- Section: General
-
Apotex vs. Large Pharma: The Battle Continues
- Section: Licensing
-
GSK Loads up the Potential Milestones from Chemocentryx
- Section: Mergers & Acquisitions
-
Serono Changes Tack Again and Finds Buyer
-
Hospira to Acquire Mayne Pharma
- Section: Research & Development
-
ISS on its own Stimulates Dynavax and AstraZeneca to collaborate on Asthma